Clinical Trial Update: Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes a phase 1/phase 2 study evaluating the combination of lurbinectedin with osimertinib in transformed small cell lung cancer, inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer
• Transformed Small Cell Lung Cancer

Drugs mentioned

• Lurbinectedin (lurbinectedin)
• Osimertinib (osimertinib)

Snippet

Sponsor: Misty Shields | Conditions: Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING